Look ahead to this year's Muscular Dystrophy Association (MDA) meeting, which will feature discussions on the latest gene therapies, clinical trial data, policy considerations, and more in the realm ...

TORONTO, March 13, 2025 (GLOBE NEWSWIRE) -- The ALS Society of Canada (ALS Canada) was honoured to be selected to recognize 39 Canadians from the ALS community across the country to receive the ...

Patients with ALS often lose their ability to speak making it harder to communicate with their family. This AI-powered device ...

Once daily treatment with Denali's oral candidate DNL343 failed to reduce NfL levels in adults with ALS in the HEALEY trial.

Anti-neurofilament L antibodies play a crucial role in detecting and monitoring neurodegenerative diseases, including Alzheimer’s disease, amyotrophic lateral sclerosis (ALS), and multiple sclerosis ...

A new study published in JAMA Network Open found a connection between dementia risk and seven heart-healthy habits. Habits ...

Much of cell behavior is governed by the actions of biomolecular condensates: building block molecules that glom together and ...

In this week’s InnovationRx newsletter, the worsening measles outbreak, a noninvasive brain-computer implant, replacing heart ...

Cognixion announced today that it launched a clinical trial evaluating its integrated, wearable augmented reality and BCI ...

Among participants who met the core RESTORE-ALS Trial criteria (e.g., baseline serum NfL > 33 pg/mL, TRICALS risk score range between –6.5 and –2.5, baseline slow vital capacity > 60%, and symptom ...

Ionis Pharmaceuticals IONS signed a license agreement with Japan-based Ono Pharmaceutical. Per the terms, Ono has acquired ...